Interleukin 18 gene transfer expands the repertoire of antitumor Th1-type immunity elicited by dendritic cell-based vaccines in association with enhanced therapeutic efficacy.

Tatsumi, Tomohide

Interleukin 18 gene transfer expands the repertoire of antitumor Th1-type immunity elicited by dendritic cell-based vaccines in association with enhanced therapeutic efficacy. [electronic resource] - Cancer research Oct 2002 - 5853-8 p. digital

Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.

0008-5472


Adenoviridae--genetics
Animals
Cancer Vaccines--genetics
Cytotoxicity, Immunologic
Dendritic Cells--immunology
Female
Gene Transfer Techniques
Immunotherapy, Adoptive--methods
Interferon-gamma--biosynthesis
Interleukin-18--genetics
Mice
Mice, Inbred BALB C
Sarcoma, Experimental--immunology
T-Lymphocytes, Cytotoxic--immunology
Th1 Cells--immunology